ROIV
NASDAQ · Biotechnology
Roivant Sciences Ltd
$34.01
+1.80 (+5.59%)
Analyst Consensus
Strong Buy
19
Analysts
High
Coverage
Price Target
Analyst Price Target
+136.5% upside
Low Target
$62.72
Average Target
$80.43
High Target
$106.86
Current Price
$34.01
Current
$34.01
$34.01
Target
$80.43
$80.43
$62.72
$80.43 avg
$106.86
Scenario Analysis
Bear Case
$62.72
84.4%
Low target
Base Case
$80.43
+136.5%
Avg target
Bull Case
$106.86
+214.2%
High target
Risk/Reward
2.5x
Favorable
Price in Context
52-Week High
$32.79
3.7% from high
52-Week Low
$10.71
+217.7% from low
50-Day SMA
$23.00
+47.9% vs SMA
200-Day SMA
$16.34
+108.1% vs SMA
RSI (14)
76.4
Overbought
Target vs 52W High
$80.43
+145.3% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 40 | 78% | $257.58 | +9.7% |
| AMGN | Hold | 44 | 50% | $190.87 | -45.7% |
| GILD | Strong Buy | 39 | 82% | $362.68 | +189.8% |
| VRTX | Strong Buy | 40 | 83% | $438.34 | -7.8% |
| REGN | Buy | 38 | 71% | $76.80 | -87.7% |
| ALNY | Strong Buy | 37 | 76% | $102.31 | -65.2% |
| RVMD | Strong Buy | 27 | 96% | $114.11 | -32.8% |
| NTRA | Strong Buy | 27 | 89% | $142.91 | -45.0% |